港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

佰泽医疗

6.760

-0.290-4.11%

成交量：119.46万

成交额：821.97万

市值：89.10亿

市盈率：-595.49

高：7.060

开：7.050

低：6.740

收：7.050

52周最高：7.600

52周最低：5.010

股本：13.18亿

香港流通股本：13.18亿

量比：0.84

换手率：0.09%

股息：- -

股息率：- -

每股收益(LYR):-0.011

净资产收益率：-0.30%

总资产收益率：0.91%

市净率：7.64

市盈率(LYR):-595.49

市销率: 6.87

数据加载中...

总览公司新闻公告

佰泽医疗06月26日主力净流入101.7万元散户资金抛售

佰泽医疗(02609)港股首秀暴涨42% 肿瘤康复共识助力行业升级

佰泽医疗共同发起“肿瘤康复五大处方”倡议书

格隆汇资讯

登陆港交所！天津经开区又一龙头企业上市

异动解读 | 佰泽医疗上市次日盘中大跌5.17%，或为获利回吐

佰泽医疗集团完成香港上市，毕马威作为其申报会计师提供专业服务

【IPO追踪】上市首日暴涨42%！佰泽医疗能否打破“高开低走”魔咒？

佰泽医疗尾盘涨幅扩大至40%，中签一手赚超1000港元

老虎资讯综合

一图看懂佰泽医疗IPO

全周期肿瘤服务领航者佰泽医疗(02609)正式挂牌港交所上市首日高开24.41%

招银国际成功保荐 Bayzed Health Group Inc香港IPO并在香港联交所主板上市

异动解读 | 佰泽医疗首日挂牌大涨22.99%，肿瘤医疗服务获市场青睐

新股首日｜药捷安康-B飙涨超64%，佰泽医疗涨超24%，三花智控破发开跌7%

老虎资讯综合

新股定价 | 佰泽医疗下限定价，公开发售获25.9倍认购，一手中签率20%

老虎资讯综合

院士加持的民营医院今日上市，肿瘤医疗再迎高光时刻

港股公告掘金 | 吉利汽车参设合资公司拓展巴西市场三花智控、佰泽医疗等三家公司明日上市

《新股》佰泽医疗(02609.HK)公开发售获25.9倍认购一手中签率20%

阿斯达克财经

佰泽医疗(02609)每股发售价4.22港元公开发售获25.92倍认购

老虎暗盘｜佰泽医疗涨超30%，中签一手赚‬768港元

老虎资讯综合

三花智控(02050)、佰泽医疗(02609)、药捷安康-B(02617)已获接纳在中央结算系统内进行结算、交收及提存

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02609/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02609","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02609\",,,,,undefined,":{"symbol":"02609","market":"HK","secType":"STK","nameCN":"佰泽医疗","latestPrice":6.76,"timestamp":1756186955172,"preClose":7.05,"halted":0,"volume":1194600,"delay":0,"floatShares":1318000000,"shares":1318000000,"eps":-0.011352,"marketStatus":"交易中","change":-0.29,"latestTime":"08-26 13:42:44","open":7.05,"high":7.06,"low":6.74,"amount":8219688,"amplitude":0.04539,"askPrice":6.76,"askSize":3600,"bidPrice":6.74,"bidSize":600,"shortable":0,"etf":0,"ttmEps":-0.011352,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1756195800000},"marketStatusCode":2,"adr":0,"listingDate":1750608000000,"exchange":"SEHK","adjPreClose":7.05,"openAndCloseTimeList":[[1756171800000,1756180800000],[1756184400000,1756195200000]],"volumeRatio":0.839407,"lotSize":600,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02609\",,,,,undefined,":{"symbol":"02609","floatShares":1318000000,"roa":"0.91%","roe":"-0.30%","lyrEps":-0.011352,"volumeRatio":0.839407,"shares":1318000000,"dividePrice":0,"high":7.06,"amplitude":0.04539,"preClose":7.05,"low":6.74,"week52Low":5.01,"pbRate":"7.64","psRate":"6.87","week52High":7.6,"institutionHeld":0,"latestPrice":6.76,"committee":-0.714286,"eps":-0.011352,"divideRate":0,"volume":1194600,"delay":0,"ttmEps":-0.011352,"open":7.05,"prevYearClose":4.22,"prevWeekClose":7.16,"prevMonthClose":6.49,"prevQuarterClose":6.17,"fiveDayClose":7.28,"twentyDayClose":6.37,"sixtyDayClose":4.22},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02609\",params:#limit:5,,,undefined,":[{"date":"2025-08-26","symbol":"02609","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02609\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02609\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02609\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02609","date":"2025-08-25","current":-632.308694,"percent":0.088889,"low":-655.144576,"twenty":-596.490791,"median":-582.715494,"eighty":-558.258755,"high":-492.081624,"avg":-581.693439,"sd":31.907323,"marketCap":9295191102},"quantilePoints":[{"date":"2025-06-20","current":-492.081624,"twenty":-492.081624,"median":-492.081624,"eighty":-492.081624,"marketCap":7231790524},{"date":"2025-06-27","current":-551.095341,"twenty":-551.095341,"median":-537.375124,"eighty":-524.87593,"marketCap":8121755629},{"date":"2025-07-04","current":-567.172112,"twenty":-564.18705,"median":-551.384774,"eighty":-534.620124,"marketCap":8359079657},{"date":"2025-07-11","current":-574.012485,"twenty":-568.540187,"median":-551.674207,"eighty":-537.566496,"marketCap":8451372335},{"date":"2025-07-18","current":-616.58395,"twenty":-577.068287,"median":-558.971658,"eighty":-540.54479,"marketCap":9071051742},{"date":"2025-07-25","current":-596.490791,"twenty":-589.259472,"median":-567.172112,"eighty":-548.775456,"marketCap":8807358377},{"date":"2025-08-01","current":-585.823371,"twenty":-589.259472,"median":-572.292685,"eighty":-551.007263,"marketCap":8596403685},{"date":"2025-08-08","current":-563.747633,"twenty":-590.513216,"median":-576.6281,"eighty":-551.558434,"marketCap":8293156316},{"date":"2025-08-15","current":-589.726565,"twenty":-590.186831,"median":-578.458416,"eighty":-556.915785,"marketCap":8662327027},{"date":"2025-08-22","current":-644.706974,"twenty":-595.216703,"median":-582.303123,"eighty":-558.25224,"marketCap":9440222452},{"date":"2025-08-25","current":-632.308694,"twenty":-596.490791,"median":-582.715494,"eighty":-558.258755,"marketCap":9295191102}],"updateTime":1756186964748},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02609\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2546733338","title":"佰泽医疗06月26日主力净流入101.7万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2546733338","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546733338?lang=zh_cn&edition=fundamental","pubTime":"2025-06-26 20:26","pubTimestamp":1750940772,"startTime":"0","endTime":"0","summary":"06月26日, 佰泽医疗股价涨10.41%，报收6.47元，成交金额1711.3万元，换手率0.21%，振幅14.85%，量比0.00。佰泽医疗今日主力资金净流入101.7万元，上一交易日主力净流出137.3万元。该股近5个交易日上涨53.32%，主力资金累计净流入51.3万元；近20日主力资金累计净流入51.3万元，其中净流入天数为2日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626203705a71ee69d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626203705a71ee69d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02609"],"gpt_icon":0},{"id":"2546787711","title":"佰泽医疗(02609)港股首秀暴涨42% 肿瘤康复共识助力行业升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2546787711","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546787711?lang=zh_cn&edition=fundamental","pubTime":"2025-06-26 19:56","pubTimestamp":1750938999,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，6月23日，中国肿瘤医疗服务领域的璀璨新星——佰泽医疗正式敲响港交所的上市锣声，迎来资本市场首秀。6月26日，佰泽医疗发布自愿性公告称，公司旗下太原和平医院作为中国医院康复医学联合体常务理事单位，于2024年5月31日在中国医院康复医学联合体成立大会上联合北京大学第三医院等全国30多家大型医疗机构共同发起“肿瘤康复五大处方”倡议书。佰泽医疗凭借先发布局，已占据行业先机。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1310357.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["07226","YANG","BK4614","02609","HSCEI","HSTECH"],"gpt_icon":0},{"id":"2546782907","title":"佰泽医疗共同发起“肿瘤康复五大处方”倡议书","url":"https://stock-news.laohu8.com/highlight/detail?id=2546782907","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546782907?lang=zh_cn&edition=fundamental","pubTime":"2025-06-26 19:18","pubTimestamp":1750936710,"startTime":"0","endTime":"0","summary":"格隆汇6月26日丨佰泽医疗公告，公司旗下太原和平医院作为中国医院康复医学联合体常务理事单位，于2024年5月31日在中国医院康复医学联合体成立大会上联合北京大学第三医院、中国中医科学院西苑医院等全国30多家大型医疗机构共同发起“肿瘤康复五大处方”倡议书。本共识基于全球最新研究与临床经验，明确了肿瘤康复的适用人群及目标，提出了肿瘤康复的系统评估标准和科学、可行的“五大处方”康复策略。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626191840978fd616&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626191840978fd616&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02609"],"gpt_icon":1},{"id":"2546776348","title":"登陆港交所！天津经开区又一龙头企业上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2546776348","media":"中宏网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546776348?lang=zh_cn&edition=fundamental","pubTime":"2025-06-26 17:11","pubTimestamp":1750929089,"startTime":"0","endTime":"0","summary":"中宏网讯6月23日，天津经开区企业佰泽医疗投资集团有限公司 在香港联合交易所正式挂牌上市，成为2025年天津市首家港股上市企业。佰泽医疗注册于天津经开区，作为区域重点培育的医疗健康标杆企业，仅用短短八年的时间便跻身中国民营肿瘤医疗集团前列。为企业打造“精准上市通道”，已成为“泰达服务”的“招牌动作”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627085056a4bff8ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627085056a4bff8ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02609"],"gpt_icon":1},{"id":"1104200833","title":"异动解读 | 佰泽医疗上市次日盘中大跌5.17%，或为获利回吐","url":"https://stock-news.laohu8.com/highlight/detail?id=1104200833","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104200833?lang=zh_cn&edition=fundamental","pubTime":"2025-06-24 09:32","pubTimestamp":1750728758,"startTime":"0","endTime":"0","summary":"港股上市新秀佰泽医疗在上市次日遭遇大跌。该股今日盘中大跌5.17%，引发市场关注。回顾佰泽医疗的上市表现，该公司于6月23日在香港联交所主板挂牌上市，首日交易表现亮眼。上市首日，佰泽医疗开盘报5.25港元，较发行价4.22港元大涨逾24%，截至收盘报6.00港元，涨幅高达42.18%。然而，在经历了如此强劲的首日表现后，佰泽医疗今日盘中出现较大幅度回调。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 佰泽医疗上市次日盘中大跌5.17%，或为获利回吐","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02609"],"gpt_icon":1},{"id":"2545256490","title":"佰泽医疗集团完成香港上市，毕马威作为其申报会计师提供专业服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2545256490","media":"毕马威KPMG","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545256490?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 17:41","pubTimestamp":1750671660,"startTime":"0","endTime":"0","summary":"佰泽医疗集团于2025年6月23日在香港联合交易所主板完成首次公开发行并上市。毕马威作为佰泽医疗香港上市的申报会计师全程参与该上市项目，并提供专业服务。2025毕马威华振会计师事务所、毕马威企业咨询（中国）有限公司及毕马威会计师事务所，均是与毕马威国际有限公司相关联的独立成员所全球组织中的成员。毕马威国际及其关联实体不提供任何客户服务。毕马威的名称和标识均属于毕马威国际的商标或注册商标。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2025-06-23/doc-infcahpc7230808.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02609"],"gpt_icon":0},{"id":"2545749416","title":"【IPO追踪】上市首日暴涨42%！佰泽医疗能否打破“高开低走”魔咒？","url":"https://stock-news.laohu8.com/highlight/detail?id=2545749416","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545749416?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 16:55","pubTimestamp":1750668907,"startTime":"0","endTime":"0","summary":"近些年来，港股市场迎来了一些肿瘤专科医疗服务相关企业上市，包括海吉亚医疗（06078.HK）、美中嘉和（02453.HK）等。","market":"us","thumbnail":"https://images.finet.hk/photoLib/title/202506_1/5a57d054-2bce-4774-831d-5a65ade0c12d.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202506_1/5a57d054-2bce-4774-831d-5a65ade0c12d.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/6859166b5a77129bb57e9796","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["02609"],"gpt_icon":1},{"id":"1171022261","title":"佰泽医疗尾盘涨幅扩大至40%，中签一手赚超1000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1171022261","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171022261?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 15:56","pubTimestamp":1750665360,"startTime":"0","endTime":"0","summary":"6月23日，$佰泽医疗(02609)$尾盘涨幅扩大至40%，总市值突破78亿港元，中签一手赚超1000港元。","market":"hk","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1a040a7e178682d0420bf03896e8d7ed","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02609"],"gpt_icon":0},{"id":"2545450263","title":"一图看懂佰泽医疗IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2545450263","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545450263?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 10:02","pubTimestamp":1750644159,"startTime":"0","endTime":"0","summary":"6月一图看懂佰泽医疗(02609.HK)IPO","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062310032895275309&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"c9538f7067679bc20adaa56712d2abee","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062310032895275309&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02609"],"gpt_icon":0},{"id":"2545502054","title":"全周期肿瘤服务领航者佰泽医疗(02609)正式挂牌港交所 上市首日高开24.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545502054","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545502054?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 10:01","pubTimestamp":1750644075,"startTime":"0","endTime":"0","summary":"6月23日，佰泽医疗集团正式登陆港交所，为投资者打开了布局中国民营肿瘤医疗市场蓬勃发展的重要窗口。上市首日公司股价开盘高开，涨幅达24.41%，报5.25港元。作为肿瘤医疗热门赛道的民营头部力量，佰泽医疗此次上市备受投资者与行业机构关注。据悉，此次IPO佰泽医疗引入Harvest Oriental作为基石投资者，认购金额约1900万美元，为上市保驾护航。业绩方面，佰泽医疗同样保持稳健增长态势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c9538f7067679bc20adaa56712d2abee","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1308239.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HEXmain","02609"],"gpt_icon":1},{"id":"2545450252","title":"招银国际成功保荐 Bayzed Health Group Inc香港IPO并在香港联交所主板上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2545450252","media":"招银国际","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545450252?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 09:44","pubTimestamp":1750643055,"startTime":"0","endTime":"0","summary":"交易概述2025年6月23日，Bayzed Health Group Inc成功于香港联合交易所主板挂牌上市。招银国际担任佰泽医疗在香港IPO的独家保荐人、整体协调人、独家全球协调人、独家账簿管理人及联席牵头经办人，助力佰泽医疗成功发行上市。佰泽医疗本次IPO招股引入1名基石投资者，为嘉实国际旗下Harvest Oriental认购1900万美元，折合约1.49亿港币，占募集资金的26.5%。招银国际融资已逐步成为香港资本市场最为活跃且增长力强劲的金融机构之一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623094635a4b80793&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623094635a4b80793&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02609"],"gpt_icon":1},{"id":"1166421968","title":"异动解读 | 佰泽医疗首日挂牌大涨22.99%，肿瘤医疗服务获市场青睐","url":"https://stock-news.laohu8.com/highlight/detail?id=1166421968","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166421968?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 09:33","pubTimestamp":1750642381,"startTime":"0","endTime":"0","summary":"港股新上市公司佰泽医疗今日盘中大涨22.99%，引发市场广泛关注。作为中国主要的肿瘤医疗集团，佰泽医疗的强劲表现凸显了投资者对肿瘤医疗服务行业的信心。佰泽医疗此次全球发售约1.33亿股，最终以每股4.22港元的发行价完成募资，净筹资约4.68亿港元。上市首日开盘价为5.25港元，较发行价上涨24.41%，截至发稿时涨幅为22.99%。分析人士指出，佰泽医疗股价的强劲表现反映了市场对严肃医疗服务的需求和认可。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c9538f7067679bc20adaa56712d2abee","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02609"],"gpt_icon":1},{"id":"1133456971","title":"新股首日｜药捷安康-B飙涨超64%，佰泽医疗涨超24%，三花智控破发开跌7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133456971","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133456971?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 09:23","pubTimestamp":1750641828,"startTime":"0","endTime":"0","summary":"6月23日，港股三只新股正式挂牌港交所，药捷安康-B飙涨超64%，公开发售获逾3400倍认购；佰泽医疗涨超24%，公开发售获近26倍认购；三花智控跌超7%。","market":"hk","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c865ffc5b7b68e9a4882237735918ecc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2328871848.SGD","BK0076","LU0359201612.USD","BK0188","LU1064130708.USD","02050","LU2238339852.HKD","LU2298064838.USD","BK0070","LU0359202008.SGD","159891","LU1023057109.AUD","BK0028","BK0197","02609","02617","LU2580892789.USD","LU2580892862.HKD","SGXZ49509284.SGD","LU1328615791.USD","BK0187","LU1969619763.USD","002050"],"gpt_icon":0},{"id":"1192605032","title":"新股定价 | 佰泽医疗下限定价，公开发售获25.9倍认购，一手中签率20%","url":"https://stock-news.laohu8.com/highlight/detail?id=1192605032","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192605032?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 08:14","pubTimestamp":1750637644,"startTime":"0","endTime":"0","summary":" $佰泽医疗(02609)$ 公布招股结果，确定以4.22港元下限定价，集资净额4.68亿港元。公开发售接获25.92倍认购，一手(600股)中签率20%，认购9,000股获稳派一手。国际发售录得0.98倍认购。经重新分配，公开发售股份已增加至1,623.84万股，占发售总数12.2%。股份预期今日(23日)上市。中国肿瘤医疗集团佰泽医疗本次拟全球发售1.33亿股，公开发售原占10%。招股价介乎4.22-6.75元。基石投资者Harvest Oriental认购1,900万美元公司股份。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/7d9d4a5b8b6d48694c54f99a84fabffd","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/7d9d4a5b8b6d48694c54f99a84fabffd"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c9538f7067679bc20adaa56712d2abee","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"新股定价 | 佰泽医疗下限定价，公开发售获25.9倍认购，一手中签率20%","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02609"],"gpt_icon":0},{"id":"2545256451","title":"院士加持的民营医院今日上市，肿瘤医疗再迎高光时刻","url":"https://stock-news.laohu8.com/highlight/detail?id=2545256451","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545256451?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 08:02","pubTimestamp":1750636926,"startTime":"0","endTime":"0","summary":"佰泽医疗业绩数据，图片来源：招股书佰泽医疗上市，加上此前的盈康生命、海吉亚医疗、美中嘉和，肿瘤医疗服务已有4家上市公司，成为上市公司最为密集的严肃医疗专科领域之一，肿瘤医疗再次在资本市场迎来高光时刻。截至2024年底，佰泽医疗体系内的医院拥有早癌筛查、肿瘤诊断、肿瘤治疗、肿瘤康复等医疗专业人员2,829名，专长包括消化系统肿瘤、泌尿系统肿瘤、肺癌及乳腺癌等病种。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623080531a717b9e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"c9538f7067679bc20adaa56712d2abee","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623080531a717b9e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02609","09906","BK1209"],"gpt_icon":1},{"id":"2545340094","title":"港股公告掘金 | 吉利汽车参设合资公司拓展巴西市场 三花智控、佰泽医疗等三家公司明日上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2545340094","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545340094?lang=zh_cn&edition=fundamental","pubTime":"2025-06-22 19:57","pubTimestamp":1750593440,"startTime":"0","endTime":"0","summary":"【重大事项】云知声(09678)6月20日至6月25日招股 预计6月30日上市泰德医药(03880)6月20日至6月25日招股 预计6月30日上市IFBH(06603)6月20日至6月25日招股 预计6月30日上市佰泽医疗(02609)每股发售价4.22港元 公开发售获25.92倍认购三花智控(02050)以上限定价 公开发售获747.92 倍认购药捷安康-B(02617)香港公开发售获3419.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1308151.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1224444064.USD","LU1939255532.USD","BK1589","EVS.SI","GELYY","BK1119","LU2328871848.SGD","LU1861214812.USD","BK1566","BK0188","BK0197","00175","BK1500","BK1521","LU0359202008.SGD","SGXZ81163826.USD","LU1969619763.USD","LU1861219969.SGD","SGXZ49509284.SGD","LU1328615791.USD","BK0028","LU0359201612.USD","LU2360107325.USD","80175","YANG","LU2148510915.USD","LU1064131003.USD","LU0640798160.USD","00384","BK0259","LU0293314216.USD","02050","BK1221","LU0315179316.USD","IE00B0JY6N72.USD","BK0187","LU1282651048.USD","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK4614","02609","LU2580892862.HKD","HSTECH","LU2580892789.USD","BK1539","LU1115378108.SGD","002050"],"gpt_icon":1},{"id":"2545434546","title":"《新股》佰泽医疗(02609.HK)公开发售获25.9倍认购  一手中签率20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545434546","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545434546?lang=zh_cn&edition=fundamental","pubTime":"2025-06-22 18:48","pubTimestamp":1750589280,"startTime":"0","endTime":"0","summary":"佰泽医疗(02609.HK)公布招股结果，公开发售接获25.92倍认购，一手(600股)中签率20%，认购9,000股获稳派一手。国际发售录得0.98倍认购。经重新分配，公开发售股份已增加至1,623.84万股，占发售总数12.2%。最终发售价4.22元，下限定价，集资净额4.68亿元。股份预期周一(23日)上市。中国肿瘤医疗集团佰泽医疗是次拟全球发售1.33亿股，公开发售原占10%。招股价介乎4.22-6.75元。基石投资者Harvest Oriental认购1,900万美元公司股份。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180207154153978_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180207154153978_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1448292/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02609"],"gpt_icon":0},{"id":"2544817828","title":"佰泽医疗(02609)每股发售价4.22港元 公开发售获25.92倍认购","url":"https://stock-news.laohu8.com/highlight/detail?id=2544817828","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544817828?lang=zh_cn&edition=fundamental","pubTime":"2025-06-20 21:51","pubTimestamp":1750427467,"startTime":"0","endTime":"0","summary":"智通财经APP讯，佰泽医疗(02609)公布配发结果，公司全球发售约1.33亿股股份，公开发售占12.2%，国际发售占87.8%。每股发售价4.22港元，净筹约4.68亿港元。每手600股，预期股份将于2025年6月23日(星期一)上午九时正开始在联交所买卖。其中，公开发售获25.92倍认购，国际发售获0.98倍认购。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c9538f7067679bc20adaa56712d2abee","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1308012.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02609"],"gpt_icon":0},{"id":"1102406827","title":"老虎暗盘｜佰泽医疗涨超30%，中签一手赚‬768港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1102406827","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102406827?lang=zh_cn&edition=fundamental","pubTime":"2025-06-20 16:15","pubTimestamp":1750407309,"startTime":"0","endTime":"0","summary":"6月20日，佰泽医疗暗盘开涨超30%，报5.5港元/股，总市值超72亿港元；不计手续费，中签一手赚768港元；公司每股定价4.22港元，每手600股，将于6月23日（周一）正式挂牌交易。截至2024年12月31日，佰泽医疗的所有六家自有医院和黄山首康医院均成立了早癌筛查与防治中心、早癌筛查中心或早癌筛查与评估中心，将早癌筛查标准在基层应用和推广，以提供早癌筛查及肿瘤诊断和治疗的连续医疗服务。","market":"us","thumbnail":"https://static.tigerbbs.com/060ad0458b052bd2b9e3c7afae3df1f5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/060ad0458b052bd2b9e3c7afae3df1f5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c9538f7067679bc20adaa56712d2abee","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02609"],"gpt_icon":1},{"id":"2544148220","title":"三花智控(02050)、佰泽医疗(02609)、药捷安康-B(02617)已获接纳在中央结算系统内进行结算、交收及提存","url":"https://stock-news.laohu8.com/highlight/detail?id=2544148220","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544148220?lang=zh_cn&edition=fundamental","pubTime":"2025-06-20 14:53","pubTimestamp":1750402406,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，6月19日，香港中央结算有限公司发布通告称，三花智控(02050)、佰泽医疗(02609)、药捷安康-B(02617)已获接纳在中央结算系统内进行结算、交收及提存。自2025年6月20日起，该等证券在联交所的买卖将透过中央结算系统进行结算；并于2025年6月23日起透过中央结算系统自动以持续净额交收制度进行交收。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"cbbb61f0deb5df3f9d66eb1cdedfdc0a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1307651.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02609","LU2580892862.HKD","LU2328871848.SGD","002050","SGXZ81163826.USD","LU1939255532.USD","LU1969619763.USD","LU2148510915.USD","BK0197","LU2580892789.USD","LU1064130708.USD","SGXZ49509284.SGD","LU0359201612.USD","LU1064131003.USD","LU2298064838.USD","BK0028","02050","LU1023057109.AUD","02617","BK0259","BK0187","LU1328615791.USD","BK0070","LU2238339852.HKD","BK0076","LU0359202008.SGD","BK0188"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":57,"code":"91000000","status":"200"}]}}